Latest News
3-6-2010: L-Nutra completes the development of the first version of ChemoLieve
9-30-2010: L-Nutra was awarded the first component of a $1.65M contract by the National Cancer Institute of the NIH.
ChemoLieve
ChemoLieve is a complete medical diet replacement aimed at providing optimal nutrition for the cancer patient undergoing chemotherapy treatment.
Contact L-Nutra
General Information
email: info@l-nutra.com
phone: (323) 580-6855
Welcome to the L-Nutra Website
L-Nutra, Inc., a California corporation, is a spin-off of the University of Southern California, formed in 2009 to develop, manufacture and market medical food for the protection against aging and age-related diseases, with initial focus on cancer and chemotherapy treatment. Its first product, ChemoLieve, is a proprietary medical food based on pre-clinical and human studies at leading research universities and centers, indicating that specific dietary formulations reduce multiple side effects of chemotherapy while maintaining or increasing chemotherapy’s efficacy. L-Nutra is also beginning to extend its research and development efforts to the prevention and treatment of other diseases of aging.